Skip to content
10-K

Annual Report

CV Sciences, Inc. CVSI

0000950170-25-046180

← back to feed
Filed
Mar 27, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 24, 2025 184.26M sh
Shares Diluted FY 2024 · Dec 31, 2023 153.96M sh
Capex FY 2024 · Dec 31, 2023 $0
Operating Cash Flow FY 2024 · Dec 31, 2023 $2.25M
Current Liabilities FY 2024 · Dec 31, 2023 $6.12M
Total Liabilities FY 2024 · Dec 31, 2023 $6.3M
Current Assets FY 2024 · Dec 31, 2023 $7.94M
Total Assets FY 2024 · Dec 31, 2023 $9.2M
Eps Diluted FY 2024 · Dec 31, 2023 $0.02
Eps Basic FY 2024 · Dec 31, 2023 $0.02
Sga Expense FY 2024 · Dec 31, 2023 $9.75M
Rd Expense FY 2024 · Dec 31, 2023 $151K
Net Income FY 2024 · Dec 31, 2023 $3.1M
Operating Income FY 2024 · Dec 31, 2023 $3.36M
Gross Profit FY 2024 · Dec 31, 2023 $7.09M
Cost Of Revenue FY 2024 · Dec 31, 2023 $8.92M
Revenue FY 2024 · Dec 31, 2023 $16M
Stockholders Equity FY 2024 · Dec 31, 2022 −$777K